Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
108.3±12.91 µg/mL
Hemolytic
Cytotoxic
50% Hemolysis | 108.3±12.91 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Indolicidin analogs with broad-spectrum antimicrobial activity and low hemolytic activity | Peptides | 2020